Practice Support Update Blog

Statewide standing orders rescinded for ineffective monoclonal antibodies

Jan 27, 2022 8:08:57 AM / by Practice Support Team

On January 24, 2022, NC State Health Director, Dr. Betsey Cuervo Tilson, rescinded the statewide standing orders for the following due to the high prevalence of the Omicron variant of the SARS-CoV-2 virus in North Carolina for which these therapies are not an effective treatment:

  • Subcutaneous Administration of Casirivimab/ Imdevimab (REGEN-COV) Monoclonal Antibodies
  •  Intravenous Administration of Casirivimab/ Imdevimab (REGEN-COV) Monoclonal Antibodies
  •  Intravenous Administration of Bamlanivimab/ Etesevimab Monoclonal Antibodies

The order for Sotrovimab remains in effect, with important patient triage prioritization given the limited supply of this therapy.


Tags: COVID-19, monoclonal antibodies

    Practice Support Services

    Health care practices in North Carolina face many challenges. Our team of quality improvement coaches (QICs) have skills and expertise to support you in your transformation efforts.

    To learn more about Practice Support Click Here

    Apply for practice support services - fill out an application here

    Subscribe to Blog Updates

    Additional Resources:
    Tip Sheets
    Lib Guides
    Interactive Resource Guides
    Digital Library
    New call-to-action
    Join email list

    Connect With Us:

    Posts by Topic

    See all

    In Case You Missed It... Check Out These Recent Posts